HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S E Strand Selected Research

Monoclonal Antibodies

4/2011Dosimetry in patients with B-cell lymphoma treated with [(90)Y]ibritumomab tiuxetan or [(131)I]tositumomab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S E Strand Research Topics

Disease

2Asphyxia (Suffocation)
12/2001 - 04/2001
1Neoplasms (Cancer)
04/2011
1B-Cell Lymphoma (Lymphoma, B Cell)
04/2011
1Brain Ischemia (Cerebral Ischemia)
12/2001
1Heart Arrest (Cardiac Arrest)
12/2001
1Ischemia
12/2001
1Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain)
04/2001
1Pain (Aches)
06/2000
1Carcinoma (Carcinomatosis)
06/2000

Drug/Important Bio-Agent (IBA)

2Glucose (Dextrose)FDA LinkGeneric
12/2001 - 04/2001
1Monoclonal AntibodiesIBA
04/2011
1RadiopharmaceuticalsIBA
04/2011
1ibritumomab tiuxetan (Zevalin)FDA Link
04/2011
1Opiate AlkaloidsIBA
12/2001
1Indicators and Reagents (Reagents)IBA
12/2001
1IsofluraneFDA LinkGeneric
12/2001
1Hormones (Hormone)IBA
06/2000

Therapy/Procedure

1Radioimmunotherapy
04/2011
1Anesthesia
12/2001
1Resuscitation
12/2001